“…MSCs are considered a promising tool for cell therapy, in particular for inflammatory diseases, based on their immunomodulatory properties and paracrine effects through trophic factors with anti-fibrotic, anti-apoptotic or pro-angiogenic properties [29,30] . MSCs regulate the function of a broad range of immune cells [30][31][32][33][34][35][36][37] , and are activated by inflammatory mediators released from activated immune cells (i.e., IFNγ, IL1β and TNFα) [38,39] . The mechanisms involved in the immunoregulatory activity of MSCs are still under investigation but rely on both cell contact-dependent mechanisms (i.e., Jagged1-Notch1 interaction, Fas-Fas-L interaction) [40,41] and paracrine effects through the release of soluble factors including hepatocyte growth factor, prostaglandin-E2 (PGE2), TGF-β1, nitric oxide (NO), IL-10, IL-6, heme oxygenase-1 (HO-1), HLA-G5 or the enzymatic activity of indoleamine 2,3-dioxygenase [42] .…”